Peanut allergy is an increasing public health concern in the United States. Children with peanut allergy may remain allergic for life, unlike children with more often outgrown allergies to milk or egg. Dr. Wesley Burks, professor and chief of the division of pediatric allergy and immunology at Duke University Medical Center, describes recent success with peanut immunotherapy in a few groups of children. Do these studies provide hope for all patients with peanut allergy, including adults? Dr. Lee Freedman hosts.
Promising Peanut Immunotherapy Studies
Share this program on:
Choose a format
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Details
Presenters
Recommended
Details
Presenters
Overview
Peanut allergy is an increasing public health concern in the United States. Children with peanut allergy may remain allergic for life, unlike children with more often outgrown allergies to milk or egg. Dr. Wesley Burks, professor and chief of the division of pediatric allergy and immunology at Duke University Medical Center, describes recent success with peanut immunotherapy in a few groups of children. Do these studies provide hope for all patients with peanut allergy, including adults? Dr. Lee Freedman hosts.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
CME/CE
Bridging Distances in PAH: Bringing Best Practices to the People Through Telementoring
1.00 credits
<p>Bridging Distances in PAH: Bringing Best Practices to the People Through Telementoring</p>
MinuteCE®
Episode 2 Part B: Effectively Transferring Over the CKD Patient at the Right Time
1.00 credits
<p>Episode 2 Part B: Effectively Transferring Over the CKD Patient at the Right Time</p>
MinuteCE®
What do we know now that could have changed the history of CETP inhibition?: genetics and biology
0.50 credits
<p>What do we know now that could have changed the history of CETP inhibition?: genetics and biology </p>
NeuroFrontiers
Respiratory Dysfunction in Neuromuscular Disorders: Evaluating Symptoms
<p>Respiratory Dysfunction in Neuromuscular Disorders: Evaluating Symptoms</p>
NeuroFrontiers
From Diagnosis to Treatment: Challenges in Glioblastoma Care
<p>From Diagnosis to Treatment: Challenges in Glioblastoma Care</p>
NeuroFrontiers
Vorasidenib and mIDH Gliomas: Reviewing the Efficacy Data
<p>Vorasidenib and mIDH Gliomas: Reviewing the Efficacy Data</p>
Clinician's Roundtable
Diagnosing and Treating Benign Prostatic Hyperplasia and Overactive Bladder
<p>Diagnosing and Treating Benign Prostatic Hyperplasia and Overactive Bladder</p>
Clinician's Roundtable
Bladders, Breakthroughs, and Bold New Therapies: Key Updates at AUA 2025
<p>Bladders, Breakthroughs, and Bold New Therapies: Key Updates at AUA 2025</p>
Register
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?